MINNEAPOLIS (August 22, 2017) – On Wednesday, August 23 and Thursday, August 24, OneOme’s director of laboratory operations, Ross Higgins, will speak about the barriers and opportunities for implementing pharmacogenomics in clinical medicine at the Precision Medicine Leaders Summit in San Diego....

Partnership is Personalized Medicine Company’s First Entry into Canadian Retail Pharmacy Market

07/26/2017

Minneapolis, Minnesota; North Bay, Ontario (July 26, 2017) – A new partnership between OneOme and ProZed Pharmacy Solutions brings the power of personalized medicine to Canada. Minnesota-based OneOme will provide its RightMed® pharmacogenomics platform exclusively to customers of ProZed Pharmacy...

Agreement will Bring OneOme’s Pharmacogenomic Testing to Patients in Mexico

07/13/2017

MINNEAPOLIS, MEXICO CITY (July 13, 2017) – Pharmacogenomics leader OneOme today announced it has forged a partnership with Mexico City-based Total Quality Medicine (TQM). The agreement will bring OneOme’s pharmacogenomic (PGx) testing and support services to patients in Mexico, as TQM incorpor...

NBC News recently featured a story on its website and during an NBC Nightly News segment about Karen Daggett, a Mayo Clinic patient who nearly died after taking a heart medication that had built up to toxic levels in her body.

• Australia’s Genome.One and U.S.-based OneOme have partnered to provide insights into individuals’ genetic risk of disease and pharmacogenomic responses • The offering is part of Australia’s first whole genome and health assessment service that provides new information to prevent or manage...